Insulet Corp. stock underperforms Tuesday when compared to competitors
Shares of Insulet Corp. PODD shed 1.03% to $265.65 Tuesday, on what proved to be an all-around grim trading session for the ...
Investor's Business Daily on MSN22h
Insulin Device Maker Has Analysts Turning Bullish
Insulet stock is near a buy point after gapping up on earnings. The company increased its full year sales guidance.
Investor's Business Daily on MSN3h
Lantheus Stock Doubled In A Year Amid Wide Use Of Its AI-Enabled Medical Devices
Artificial intelligence is the watchword for investors, but some analysts also see strength this year in the medical sector.
Insulet Corp. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today
Buying $100 In PODD: If an investor had bought $100 of PODD stock 10 years ago, it would be worth $598.02 today based on a ...
Bank of America Securities Keeps Their Buy Rating on Insulet (PODD)
Bank of America Securities analyst Travis Steed maintained a Buy rating on Insulet (PODD – Research Report) yesterday and set a price target of ...
Insulet price target raised to $324 from $264 at TD Cowen
TD Cowen raised the firm’s price target on Insulet (PODD) to $324 from $264 and keeps a Buy rating on the shares. The firm thinks Insulet will ...
What Does Insulet Corporation's (NASDAQ:PODD) Share Price Indicate?
Insulet Corporation ( NASDAQ:PODD ) saw a double-digit share price rise of over 10% in the past couple of months on ...
TD Cowen Boosts Insulet (NASDAQ:PODD) Price Target to $324.00
Insulet (NASDAQ:PODD – Get Free Report) had its target price increased by investment analysts at TD Cowen from $264.00 to ...
Heavy Interest in Insulet’s Insulin Delivery Device
Insulet develops, manufactures, and markets the Omnipod Insulin Management System for those with Type 2 diabetes. The system ...
Looking Into Insulet's Recent Short Interest
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An ...
Insulet price target raised to $300 from $270 at BTIG
BTIG raised the firm’s price target on Insulet (PODD) to $300 from $270 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models in select Medical Technology ...